Arthur ("Art") Cohn is a corporate attorney who advises life sciences, biotech, medical device, healthcare and technology companies, universities and non-profit foundations in connection with technology transactions. He leverages over 30 years of transactional experience, including over 25 years of in-house experience at global pharmaceutical companies, to represent clients in a broad range of commercial and corporate activities, including early-, mid- and late-stage licensing and development agreements, global collaboration, commercialization and promotional agreements, product acquisitions and divestitures, merger and acquisitions, other strategic transactions and private company financings.
Art's clients range from universities and non-profit foundations to emerging growth companies to Fortune 500 companies throughout the world, specifically in the life sciences and technology sectors.
In addition, Art advises clients on day-to-day commercial matters and commercial agreements, such as consulting agreements, material transfer agreements, research and development agreements, clinical trial agreements, joint development agreements, licenses, manufacturing and distribution agreements, promotional agreements, joint ventures and corporate partnering arrangements. He has a depth of experience in commercial contracts and management of large commercial contract portfolios for global clients.
